Neither propranolol nor metoprolol is universally better. The right choice depends on what you’re taking it for, whether you have asthma or other lung conditions, and how sensitive you are to side effects like sleep disruption. Both drugs block the same type of receptor in the heart, but they differ in how precisely they target that receptor, how deeply they penetrate the brain, and how they affect the airways.
How They Work Differently
Both propranolol and metoprolol slow the heart rate and lower blood pressure by blocking beta-adrenergic receptors. The key difference is selectivity. Metoprolol is classified as “cardioselective,” meaning it preferentially blocks beta-1 receptors found mainly in the heart. Propranolol is non-selective, blocking both beta-1 receptors in the heart and beta-2 receptors found in the lungs, blood vessels, and elsewhere.
In practice, though, metoprolol’s selectivity is more modest than many people assume. Lab research published in the British Journal of Pharmacology measured the actual receptor binding of common beta-blockers in human cells and found metoprolol had a beta-1 to beta-2 selectivity ratio of just 2.3, compared to drugs like bisoprolol at 14. Propranolol’s ratio was 8.3, but in the opposite direction: it actually had higher affinity for beta-2 receptors. This matters because beta-2 blockade is what causes the unwanted effects in the lungs and can mask low blood sugar symptoms in people with diabetes.
Migraine Prevention
Both drugs are used to prevent migraines, but propranolol has a larger evidence base and a bigger effect size. A systematic review and meta-analysis found that propranolol reduced episodic migraines by about 1.5 headaches per month at eight weeks, bringing patients from an average of 4.8 down to roughly 3.3 headaches monthly. Metoprolol reduced migraines by about 0.86 headaches per month over the same period. Both outperformed placebo, but propranolol’s reduction was nearly twice as large.
This stronger effect likely relates to propranolol’s greater ability to cross into the brain. Propranolol is classified as highly lipophilic (fat-soluble), which means it passes easily through the blood-brain barrier. Metoprolol is moderately lipophilic. It still reaches the brain, but not as readily. For conditions where central nervous system activity matters, like migraines, this difference can translate into a clinical edge.
Anxiety and Performance Symptoms
Propranolol is the beta-blocker most commonly prescribed for situational anxiety, particularly the physical symptoms: racing heart, shaking hands, sweaty palms, and trembling voice. Its ability to block beta-2 receptors throughout the body, combined with strong brain penetration, makes it effective at dampening the full-body adrenaline response that accompanies stage fright or public speaking anxiety.
One small study did find metoprolol reduced anxiety symptoms more effectively than propranolol with fewer side effects. However, the study’s own author acknowledged it was too small and too short to draw firm conclusions, and it wasn’t blinded. The bulk of the clinical literature on performance anxiety involves propranolol, and it remains the standard choice for this use.
Essential Tremor
Propranolol is the first-line treatment for essential tremor, and metoprolol can serve as an alternative. In a double-blind controlled study comparing the two, propranolol reduced tremor by 55% and metoprolol by 47%. The difference was not statistically significant, meaning both drugs performed in a comparable range. If you can’t tolerate propranolol for other reasons, metoprolol is a reasonable substitute for tremor control.
Respiratory Safety
This is where metoprolol has a clear advantage. If you have asthma or chronic obstructive pulmonary disease, propranolol poses a real risk. Blocking beta-2 receptors in the airways can trigger bronchospasm, and research consistently shows that non-selective beta-blockers like propranolol cause meaningful drops in lung function in asthma patients. One meta-analysis found a statistically significant decline in FEV1 (the standard measure of how much air you can forcefully exhale) with non-selective beta-blockers compared to placebo. Propranolol specifically has been linked to a higher risk of asthma attacks.
Metoprolol, as a cardioselective agent, is much safer for the lungs. In the same pooled analysis, cardioselective beta-blockers did not cause a statistically significant reduction in lung function. Current guidelines still recommend caution: if you have asthma and need a beta-blocker for a strong cardiovascular reason, a cardioselective option like metoprolol can be started at a low dose with monitoring. Propranolol should be avoided entirely in people at risk for asthma.
Sleep and Central Nervous System Effects
Both drugs can disrupt sleep, but propranolol tends to do so more. Lipophilic beta-blockers cross into the brain and increase the number of nighttime awakenings, reduce the amount of time spent in REM sleep, and can cause vivid dreams or nightmares. They’ve also been associated with daytime drowsiness, even when taken in the morning. According to the American College of Cardiology, both propranolol and metoprolol fall into the lipophilic category and share these risks.
That said, propranolol’s higher lipophilicity means it reaches brain tissue more readily and tends to produce these effects more frequently. If you’re experiencing nightmares or disrupted sleep on propranolol, switching to metoprolol (or a hydrophilic beta-blocker like atenolol) may help. Some people on metoprolol experience no sleep issues at all, while others notice mild effects.
Dosing Convenience
Both drugs come in extended-release formulations that allow once-daily dosing. Standard propranolol has a short half-life and typically requires two or three doses per day. The long-acting version extends the half-life to 8 to 11 hours and maintains steady blood levels over a full 24-hour period. Metoprolol succinate (the extended-release form) is also dosed once daily. If you’re comparing immediate-release versions, metoprolol’s slightly longer duration means it may need fewer daily doses than standard propranolol.
Which One Fits Your Situation
For heart-related conditions like high blood pressure, heart failure, or post-heart attack care, metoprolol is typically the preferred choice. Its selectivity for the heart, lower risk of airway problems, and somewhat milder central nervous system profile make it the more straightforward cardiovascular drug.
For migraines, essential tremor, or physical symptoms of anxiety, propranolol generally performs better. Its broader receptor blockade and deeper brain penetration give it advantages for conditions driven by the nervous system and adrenaline surges throughout the body.
If you have asthma or COPD, that single factor often settles the question in favor of metoprolol. And if sleep disturbance is a priority concern, metoprolol’s moderate (rather than high) lipophilicity gives it a slight edge, though neither drug is free of this risk.